Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

DFTX

Definium Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · DFTX

All alert types
36.33 USD -1.63 -4.29%
As of Oct 30, 2026 Extended hours 36.36 +0.09%
Bid
36.33 × 2
Ask
36.35 × 2
35.87 Day range 37.90
10.68 52-week range 48.45
YTD
+171.32%
1 year
+171.32%
Open
37.24
Prev close
37.96
Mkt cap
4.88B
Vol
1.08M
Avg vol
2.17M
EPS
-3.43
P/E
0.00
Div yield
0.00%
More statistics
Low
35.87
High
37.90
Forward P/E
-18.72
Beta
2.19
Short ratio
4.32
Inst. own
88.54%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
37.95
200-d avg
29.50
1y target
72.56

5D chart

Chart tools
Interval
1m5m15m30m
DFTX five-day price chart34.835.836.938.039.1Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

14.05 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -6.5×
FY 2016: -1.5×FY 2017: -1.2×FY 2018: -0.5×FY 2019: -0.2×FY 2020: -23.8×FY 2021: -6.1×FY 2022: -1.4×FY 2023: -1.5×FY 2024: -4.5×FY 2025: -6.5×
FY 2016 5y median -4.5× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.6×
FY 2016: 2.1×FY 2017: 0.4×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 10.7×FY 2021: 3.7×FY 2022: 0.4×FY 2023: 1.8×FY 2024: 2.0×FY 2025: 3.6×
FY 2016 5y median 2.0× FY 2025
P/FCF -9.1×
FY 2016: -4.8×FY 2017: -0.5×FY 2018: -0.3×FY 2019: -0.5×FY 2020: -34.4×FY 2021: -12.4×FY 2022: -1.4×FY 2023: -2.2×FY 2024: -6.2×FY 2025: -9.1×
FY 2016 5y median -6.2× FY 2025
EV/EBITDA -5.3×
FY 2016: -2.3×FY 2017: -1.0×FY 2018: -0.4×FY 2019: -0.2×FY 2020: -22.0×FY 2021: -4.7×FY 2022: 1.4×FY 2023: -0.6×FY 2024: -2.3×FY 2025: -5.3×
FY 2016 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -11.0%
FY 2016: -20.9%FY 2017: -195.7%FY 2018: -376.8%FY 2019: -195.0%FY 2020: -2.9%FY 2021: -8.1%FY 2022: -73.9%FY 2023: -44.9%FY 2024: -16.1%FY 2025: -11.0%
FY 2016 5y median -16.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -55.3%
FY 2016: -141.3%FY 2017: -31.1%FY 2018: -24.3%FY 2019: -40.8%FY 2020: -44.9%FY 2021: -61.3%FY 2022: -37.6%FY 2023: -122.5%FY 2024: -45.0%FY 2025: -55.3%
FY 2016 5y median -55.3% FY 2025
ROIC -44.5%
FY 2016: -87.4%FY 2017: -31.2%FY 2018: -24.5%FY 2019: -17.1%FY 2020: -42.1%FY 2021: -60.4%FY 2022: -43.6%FY 2023: -101.7%FY 2024: -39.5%FY 2025: -44.5%
FY 2016 5y median -44.5% FY 2025
ROA -41.8%
FY 2016: -88.7%FY 2017: -30.5%FY 2018: -24.3%FY 2019: -38.0%FY 2020: -41.8%FY 2021: -56.7%FY 2022: -33.4%FY 2023: -76.9%FY 2024: -36.0%FY 2025: -41.8%
FY 2016 5y median -41.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -60.0%
FY 2016: -17.7%FY 2017: -1010.2%FY 2018: 30.2%FY 2019: 45.7%FY 2020: -6955.0%FY 2021: -184.1%FY 2022: 29.3%FY 2023: -41.5%FY 2024: -10.7%FY 2025: -60.0%
FY 2016 FY 2025
EPS (diluted) -1273.3%
FY 2016: -91.5%FY 2017: -116.5%FY 2018: 43.5%FY 2019: -7.3%FY 2020: 34.7%FY 2021: -77.1%FY 2022: 55.0%FY 2023: -59.5%FY 2024: 93.9%FY 2025: -1273.3%
FY 2016 FY 2025
Free Cash Flow -66.3%
FY 2016: -21.9%FY 2017: -4862.7%FY 2018: 37.3%FY 2019: 70.5%FY 2020: -4424.2%FY 2021: -94.2%FY 2022: -9.4%FY 2023: -28.4%FY 2024: -22.9%FY 2025: -66.3%
FY 2016 FY 2025

Financial Health

Current Ratio 6.3×
FY 2016: 1.8×FY 2017: 22.0×FY 2018: 24.1×FY 2019: 14.8×FY 2020: 27.1×FY 2021: 13.2×FY 2022: 8.2×FY 2023: 3.2×FY 2024: 7.2×FY 2025: 6.3×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 6.3×
FY 2016: 1.8×FY 2017: 22.0×FY 2018: 24.1×FY 2019: 14.8×FY 2020: 27.1×FY 2021: 13.2×FY 2022: 8.2×FY 2023: 3.2×FY 2024: 7.2×FY 2025: 6.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 0.1×FY 2017: -0.0×FY 2018: 0.2×FY 2019: 0.0×FY 2020: 2.4×FY 2021: 1.5×FY 2022: 2.7×FY 2023: 0.9×FY 2024: 2.4×FY 2025: 1.4×
FY 2016 5y median 1.5× FY 2025
Interest Coverage -30.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -201×FY 2021: -261×FY 2022: -44.4×FY 2023: -102×FY 2024: -45.5×FY 2025: -30.3×
FY 2016 5y median -45.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31